These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Angioplasty with drug coated balloons for the treatment of infrainguinal peripheral artery disease. Werner M. Vasa; 2016 Sep; 45(5):365-72. PubMed ID: 27351416 [Abstract] [Full Text] [Related]
10. Prime time for drug eluting balloons in SFA interventions? Brodmann M. J Cardiovasc Surg (Torino); 2014 Aug 09; 55(4):461-4. PubMed ID: 24941235 [Abstract] [Full Text] [Related]
11. How should I treat a restenosis after superficial femoral artery stenting? Fusaro M, Cassese S, Byrne RA. EuroIntervention; 2013 Mar 09; 8(11):1342-5. PubMed ID: 23538161 [No Abstract] [Full Text] [Related]
12. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study. Grotti S, Liistro F, Angioli P, Ducci K, Falsini G, Porto I, Ricci L, Ventoruzzo G, Turini F, Bellandi G, Bolognese L. J Endovasc Ther; 2016 Feb 09; 23(1):52-7. PubMed ID: 26511896 [Abstract] [Full Text] [Related]
13. Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany. Pietzsch JB, Geisler BP, Garner AM, Zeller T, Jaff MR. Catheter Cardiovasc Interv; 2014 Oct 01; 84(4):546-54. PubMed ID: 24782424 [Abstract] [Full Text] [Related]
14. Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. Mehrotra S, Paramasivam G, Mishra S. Curr Cardiol Rep; 2017 Feb 01; 19(2):10. PubMed ID: 28185166 [Abstract] [Full Text] [Related]
15. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis. Herten M, Torsello GB, Schönefeld E, Imm B, Osada N, Stahlhoff S. J Vasc Surg; 2015 Feb 01; 61(2):394-9. PubMed ID: 25307133 [Abstract] [Full Text] [Related]
16. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. Zeller T, Rastan A, Macharzina R, Tepe G, Kaspar M, Chavarria J, Beschorner U, Schwarzwälder U, Schwarz T, Noory E. J Endovasc Ther; 2014 Jun 01; 21(3):359-68. PubMed ID: 24915582 [Abstract] [Full Text] [Related]
17. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty. Marmagkiolis K, Hakeem A, Choksi N, Al-Hawwas M, Edupuganti MM, Leesar MA, Cilingiroglu M. Catheter Cardiovasc Interv; 2014 Oct 01; 84(4):555-64. PubMed ID: 24740749 [Abstract] [Full Text] [Related]
19. Mortality After Paclitaxel Coated Balloon Angioplasty and Stenting of Superficial Femoral and Popliteal Artery in the Vascular Quality Initiative. Bertges DJ, Sedrakyan A, Sun T, Eslami MH, Schermerhorn M, Goodney PP, Beck AW, Cronenwett JL, Eldrup-Jorgensen J. Circ Cardiovasc Interv; 2020 Feb 01; 13(2):e008528. PubMed ID: 32069110 [Abstract] [Full Text] [Related]